Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T19:00:33.017Z.
Calculation as of: 2026-10-06T19:00:33.017Z.
Quote observation: 2026-10-06T19:00:07.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 47b7d046e53ba400f53df530976eb059ace8f079140d97e9bcfa36b682aba175
PEG RATIO
N/A
| NAME | MARKET CAP | PEG RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Assembly Biosciences, Inc. (ASMB) | $442.12M | N/A | N/A | N/A | N/A |
| NeuroPace, Inc. (NPCE)vs › | $442.20M | N/A | N/A | N/A | N/A |
| Capricor Therapeutics, Inc. (CAPR)vs › | $443.12M | N/A | N/A | N/A | N/A |
| Tectonic Therapeutic, Inc. (TECX)vs › | $436.34M | N/A | N/A | N/A | N/A |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $447.77M | N/A | N/A | N/A | N/A |
| Ovid Therapeutics Inc. (OVID)vs › | $448.87M | N/A | N/A | N/A | N/A |
| Editas Medicine, Inc. (EDIT)vs › | $430.46M | N/A | N/A | N/A | N/A |
| NRC Health (NRC)vs › | $453.45M | N/A | 6.07 | 3.14 | 2.42 |
| NeoGenomics, Inc. (NEO)vs › | $427.05M | N/A | 4.41 | 4.41 | 4.41 |
| Tilray Brands, Inc. (TLRY)vs › | $426.64M | N/A | N/A | N/A | N/A |
PEG Ratio
N/A
P/E Ratio
40.6
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
